Understanding how to change cell types for medical purposes
Determinants of Cell State Reprogramming
['FUNDING_OTHER'] · UT SOUTHWESTERN MEDICAL CENTER · NIH-11094093
This study is looking at what helps or hinders the process of changing one type of cell into another, which is important for developing new treatments in medicine, and it's for anyone interested in how we can improve therapies by making specific types of cells more easily.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UT SOUTHWESTERN MEDICAL CENTER (nih funded) |
| Locations | 1 site (DALLAS, UNITED STATES) |
| Trial ID | NIH-11094093 on ClinicalTrials.gov |
What this research studies
This research investigates the factors that influence the ability to reprogram cells from one type to another, which is crucial for regenerative medicine. By examining the genetic and molecular mechanisms involved in cell state conversion, the study aims to identify why some reprogramming attempts succeed while others fail. The researchers will utilize advanced techniques to analyze how different factors, such as epigenetics and initial cell states, affect the reprogramming process. This work could lead to more effective methods for generating specific cell types needed for therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could be treated through cell therapy or regenerative medicine.
Not a fit: Patients who do not have conditions requiring cell reprogramming or those who are not candidates for cell-based therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved techniques for generating specialized cells for regenerative medicine, potentially benefiting patients with various conditions.
How similar studies have performed: Previous research has shown promise in cell reprogramming techniques, indicating that this area of study has the potential for significant advancements.
Where this research is happening
DALLAS, UNITED STATES
- UT SOUTHWESTERN MEDICAL CENTER — DALLAS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HON, GARY CHUNG — UT SOUTHWESTERN MEDICAL CENTER
- Study coordinator: HON, GARY CHUNG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.